Primary Preventive Ventricular Tachycardia Ablation in High-Risk Patients Who Receive a Prophylactic Implantable Cardioverter Defibrillator

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
This prospective, multicenter, open-label, randomized-controlled trial compares two treatment strategies in high-risk ischemic cardiomyopathy (ICM) patients referred for primary ICD implantation. Participants will be randomized to receive either prophylactic VT ablation within three months of ICD implantation or continued medical management. The primary objective is to assess the efficacy of preventive VT ablation versus medical management in reducing VT arrhythmia burden.
Epistemonikos ID: 7b23d4e9c49c052ac7a0c37a154006a2538552b5
First added on: Apr 17, 2025